A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophagesBiochimie, 2009
- Confronting the scientific obstacles to global control of tuberculosisJournal of Clinical Investigation, 2008
- Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune responseGlycoconjugate Journal, 2008
- Peripheral Blood Gamma Interferon Release Assays Predict Lung Responses andMycobacterium tuberculosisDisease Outcome in MiceClinical and Vaccine Immunology, 2008
- Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosisVaccine, 2007
- Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytesMedical Microbiology and Immunology, 2007
- Lactoferrin decreases pollen antigen‐induced allergic airway inflammation in a murine model of asthmaImmunology, 2006
- Causal Vaccine Effects on Binary Postinfection OutcomesJournal of the American Statistical Association, 2006
- A Mutant of Mycobacterium tuberculosis H37Rv That Lacks Expression of Antigen 85A Is Attenuated in Mice but Retains Vaccinogenic PotentialInfection and Immunity, 2004
- Comparison of heparin‐binding to lactoferrin from human milk and from human granulocytes by means of affinity capillary electrophoresisElectrophoresis, 1996